Observe Medical ASAFRA:OM50 -1.54%32 PB Ratio is 4.71 as of Jul. 12, 2026, which is 48% above its 10-year median of 3.18. GuruFocus rates FRA:OM50 with a GF Score™ of 32/100 and a GF Value™ of €0.02. The stock has 5 warning signs investors should review. Among 788 Medical Devices & Instruments companies, Observe Medical ASA ranks worse than 79.44% on this metric.
Observe Medical ASA stock PB Ratio (=4.91) is close to 3-year high of 5.45.
The historical rank and industry rank for Observe Medical ASA's PB Ratio or its related term are showing as below:
FRA:OM50'
s PB Ratio Range Over the Past 10 Years
Min: 0.12 Med: 3.18 Max: 32.37
Current: 4.91
During the past 10 years, Observe Medical ASA's highest PB Ratio was 32.37. The lowest was 0.12. And the median was 3.18.
FRA:OM50's PB Ratio is ranked worse than 79.44% of 788
companies
in the Medical Devices & Instruments industry
Industry Median: 2.065
vs FRA:OM50: 4.91
During the past 12 months, Observe Medical ASA's average Book Value Per Share Growth Rate was -65.80% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -77.50% per year.
During the past 10 years, the highest 3-Year average Book Value Per Share Growth Rate of Observe Medical ASA was 54.60% per year. The lowest was -77.50% per year. And the median was -0.40% per year.
Back to Basics: PB Ratio
Observe Medical ASA (FRA:OM50) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Observe Medical ASA PB Ratio Related Terms
Observe Medical ASA PB Ratio Historical Data
* Premium members only.
The historical data trend for Observe Medical ASA's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Observe Medical ASA's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Observe Medical ASA PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Observe Medical ASA's PB Ratio distribution charts can be found below:
* The bar in red indicates where Observe Medical ASA's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Observe Medical ASA (FRA:OM50) has a PB Ratio of 4.71 as of Jul. 12, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Observe Medical ASA and its competitors. This is 48% above median its historical median of 3.18. Over the past decade, Observe Medical ASA's PB Ratio has ranged from 0.12 to 32.37. According to the industry distribution chart, Observe Medical ASA ranks #626 out of 788 companies in the Medical Devices & Instruments industry, placing it in the top 79.4%.
Is Observe Medical ASA's PB Ratio too high?
Observe Medical ASA's current PB Ratio of 4.71 is 48% above median its 10-year median of 3.18. Over the past 10 years, this metric has ranged from a low of 0.12 to a high of 32.37. The Medical Devices & Instruments industry median PB Ratio is 2.07. Observe Medical ASA's value of 4.71 is 128.1% above this industry median. Based on the distribution chart, Observe Medical ASA ranks #626 out of 788 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Observe Medical ASA has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Observe Medical ASA's PB Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Observe Medical ASA ranks #626 out of 788 companies for PB Ratio. This places Observe Medical ASA in the lower half of its industry. The industry median PB Ratio is 2.07. Observe Medical ASA's value of 4.71 is 128.1% above this benchmark. Historically, Observe Medical ASA's own PB Ratio has ranged from 0.12 to 32.37 over the past decade. While the company's 10-year median is 3.18 vs. the industry median of 2.07, Observe Medical ASA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.07, based on 788 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Observe Medical ASA's current PB Ratio of 4.71 is 128.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Observe Medical ASA and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Observe Medical ASA's current PB Ratio is 4.71, which is 48% above median its own 10-year median of 3.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Observe Medical ASA stock overvalued right now?
Observe Medical ASA (FRA:OM50) has a current PB Ratio of 4.71. The stock's GF Value™ is €0.02, compared to a current price of €0.09 — trading 347% above its estimated fair value. The current PB Ratio is 4.71, which is 48% above median its 10-year median of 3.18 and 128.1% above the Medical Devices & Instruments industry median of 2.07. Observe Medical ASA's overall GF Score™ is 32/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Observe Medical ASA (FRA:OM50), the current PB Ratio is 4.71 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Observe Medical ASA (FRA:OM50) Overvalued in 2026?
Based on GuruFocus' analysis, Observe Medical ASA stock appears to be overvalued.
The current stock price of €0.09 is trading 347% above its estimated GF Value™ of €0.02.
Key valuation signals for FRA:OM50:
PB Ratio: 4.71 (48% above median its 10-year median of 3.18)
GF Value™: €0.02 vs. price of €0.09 (347% above fair value)
Industry Position: 128.1% above the Medical Devices & Instruments median (#626 of 788)
No single metric tells the full story. See the FRA:OM50 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Observe Medical ASA is a Nordic medtech company focused on the development, commercialization, and scaling of medical technologies for the healthcare markets. The company's portfolio of proprietary products consists of: Sippi, a CE marked digitalized system for urine output measurement, the UnoMeter portfolio consisting of manual urine output measurement products and solutions for measuring intra-abdominal pressure. The company operates internationally through subsidiaries in Norway, Sweden and Denmark.
32GF Score
Get the complete analysis for FRA:OM50
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:OM50 has been successfully added to your 
